Loading company…
ZipBio uses AI to develop compact proteins for therapeutic applications.
Founded in 2023, ZipBio is based in Washington, US. Its COMPACT platform compresses biological structures into smaller molecules while aiming to retain their function, with a focus on ophthalmology and preclinical programs. The company also develops AI tools for gene and protein compression. In September 2024, ZipBio raised USD 4 million in seed funding led by NFX, with MoreVC participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in